Cell-free DNA as a biomarker in diffuse large B-cell lymphoma: A systematic review-Reference-Cited by-同舟云学术

Cell-free DNA as a biomarker in diffuse large B-cell lymphoma: A systematic review

Published:2019-07 Issue: Volume:139 Page:7-15
ISSN:1040-8428
Container-title:Critical Reviews in Oncology/Hematology
language:en
Short-container-title:Critical Reviews in Oncology/Hematology

Author:

Arzuaga-Mendez Javier,Prieto-Fernández Endika^ORCID,Lopez-Lopez Elixabet,Martin-Guerrero Idoia,García-Ruiz Juan Carlos,García-Orad Africa

Funder

Basque Government

EiTB maratoia (Bioef)

Publisher

Elsevier BV

Subject

Oncology,Hematology

Reference75 articles.

1. Cell free DNA and Procalcitonin as early markers of complications in ICU patients with multiple trauma and major surgery;Ahmed;Clin. Lab.,2016

2. Multiplex droplet digital PCR quantification of recurrent somatic mutations in diffuse large B-Cell and follicular lymphoma;Alcaide;Clin. Chem.,2016

3. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling;Alizadeh;Nature,2000

4. Prognostic significance of aberrant promoter hypermethylation of CpG islands in patients with diffuse large B-cell lymphomas;Amara;Ann. Oncol.,2008

5. Tumor-specific methylations in circulating cell-free DNA as clinically applicable markers with potential to substitute mutational analyses;Andersen;Expert Rev. Mol. Diagn.,2018

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Assessment of circulating free DNA as a non-invasive biomarker for diffuse large B-cell lymphoma in Egyptian patients;Alexandria Journal of Medicine;2024-07-23

2. Cell‐free DNA‐associated multi‐feature applications in cancer diagnosis and treatment;Clinical and Translational Discovery;2024-03-07

3. Circulating Tumor DNA Reflects Histologic and Clinical Characteristics of Various Lymphoma Subtypes;Cancer Research and Treatment;2024-01-15

4. Cell-Free DNA as a Biomarker at Diagnosis and Follow-Up in 256 B and T-Cell Lymphomas;Cancers;2024-01-11

5. The implication of next-generation sequencing in the diagnosis and clinical management of non-Hodgkin lymphomas;Frontiers in Oncology;2023-11-08